Artykuły w czasopismach na temat „MEIS Inhibitors”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „MEIS Inhibitors”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Kocabas, F., S. N. Eren, M. Uslu i M. Y. Yuksel. "P69Identification of cardiogenic and hematopoietic MEIS Inhibitors". Cardiovascular Research 114, suppl_1 (1.04.2018): S18—S19. http://dx.doi.org/10.1093/cvr/cvy060.033.
Pełny tekst źródłaGİRGİN, Birkan, Medine KARADAĞ-ALPASLAN i Fatih KOCABAŞ. "Oncogenic and tumor suppressor function of MEIS and associated factors". TURKISH JOURNAL OF BIOLOGY 44, nr 6 (14.12.2020): 328–55. http://dx.doi.org/10.3906/biy-2006-25.
Pełny tekst źródłaBarbosa, Karina, Anagha Deshpande, Ping Xiang, Bo-Rui Chen, Adam Brown, Neil Robertson, Younguk Sun i in. "High-Density Domain-Focused CRISPR Screens Reveal Epigenetic Regulators of Hox/Meis Gene Expression in Acute Myeloid Leukemia". Blood 136, Supplement 1 (5.11.2020): 2–3. http://dx.doi.org/10.1182/blood-2020-141412.
Pełny tekst źródłaBisaillon, Richard, Eva Schmidt, Anne-Sophie Guenier i Guy Sauvageau. "Identification of MEIS-PBX inhibitors as potential anti-leukemic agents using a high-throughput bret-based assay". Experimental Hematology 41, nr 8 (sierpień 2013): S51. http://dx.doi.org/10.1016/j.exphem.2013.05.201.
Pełny tekst źródłaCastellet, Helena, Guillermo Ramil López, Ana Garrido, Alícia Artigas-Baleri, Marta Pratcorona, Olga Salamero, Albert Cortés-Bullich i in. "Ubtf tandem Duplications Define a Novel Subtype of Acute Myeloid Leukemia Associated with Younger Age, WT1 Mutations and HOXA9 Marked Overexpression". Blood 142, Supplement 1 (28.11.2023): 6045. http://dx.doi.org/10.1182/blood-2023-186064.
Pełny tekst źródłaBreitinger, Constanze, Emanuel Maethner, Maria-Paz Garcia-Cuellar, Alexandra Schambony, Kirsten Schilling, Klaus D. Fischer i Robert K. Slany. "Hox Genes Regulate Rac1 Activity Through Control of Vav2 expression". Blood 118, nr 21 (18.11.2011): 60. http://dx.doi.org/10.1182/blood.v118.21.60.60.
Pełny tekst źródłaJarocha, Danuta Jadwiga, Paul Gadue, Wei Tong, Robert C. Newton i Mortimer Poncz. "Janus Kinase (Jak) 1 Inhibition Affects Both Megakaryopoiesis and Thrombopoiesis". Blood 132, Supplement 1 (29.11.2018): 2559. http://dx.doi.org/10.1182/blood-2018-99-115407.
Pełny tekst źródłaHaneline, Laura S., Khadijeh R. Bijangi-Vishehsaraei, Adam Werne, Kristina Wilson McKenzie, Susanna Davis, Hidenori Ichijo i Mohammad R. Saadatzadeh. "TNF-α Hypersensitivity of Fanconi Anemia Type C Deficient Cells Is Dependent on the Apoptosis Signal-Regulating Kinase 1 Signaling Pathway." Blood 104, nr 11 (16.11.2004): 724. http://dx.doi.org/10.1182/blood.v104.11.724.724.
Pełny tekst źródłaWang, Wei, Peng Li, Annette Schettino, Zhe Peng i Maureen McLeod. "Characterization of Functional Regions in the Schizosaccharomyces pombe mei3 Developmental Activator". Genetics 150, nr 3 (1.11.1998): 1007–18. http://dx.doi.org/10.1093/genetics/150.3.1007.
Pełny tekst źródłaKAYA, Mustafa Oğuzhan. "Out-of-mind Inhibitors Of Human Serum Paraoxonase 1 (PON1): An In Vitro study". Middle East Journal of Science 3, nr 1 (26.08.2017): 59–77. http://dx.doi.org/10.23884/mejs.2017.3.1.07.
Pełny tekst źródłaAgarwal, Archana, Gregory Russell Pond, Catherine Curran, Amin Nassar, Pier Vitale Nuzzo, Vivek Kumar, Bradley Alexander McGregor i in. "Impact of concurrent medications on outcomes with PD1/PD-L1 inhibitors for metastatic urothelial carcinoma." Journal of Clinical Oncology 37, nr 7_suppl (1.03.2019): 435. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.435.
Pełny tekst źródłaAltman, Jessica K., Heather Glaser, Amanda Redig, Antonella Sassano, Martin S. Tallman i Leonidas C. Platanias. "Targeting the Mnk Pathway Enhances Chemotherapy-Induced Antileukemic Responses." Blood 112, nr 11 (16.11.2008): 1617. http://dx.doi.org/10.1182/blood.v112.11.1617.1617.
Pełny tekst źródłaWaters, Andrew Michael, Wen-Hsuan Chang, Clint Stalnecker, Cole Edwards, Runying Yang, Craig M. Goodwin, Adrienne D. Cox i Channing J. Der. "Abstract 1075: Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer". Cancer Research 83, nr 7_Supplement (4.04.2023): 1075. http://dx.doi.org/10.1158/1538-7445.am2023-1075.
Pełny tekst źródłaMattos, Daphne R., Xuemei Wan, Jeffrey D. Serrill, Minh H. Nguyen, Ian R. Humphreys, Benoit Viollet, Amos B. Smith, Kerry L. McPhail i Jane E. Ishmael. "The Marine-Derived Macrolactone Mandelalide A Is an Indirect Activator of AMPK". Marine Drugs 20, nr 7 (27.06.2022): 418. http://dx.doi.org/10.3390/md20070418.
Pełny tekst źródłaDelgado, Irene, Alejandra C. López-Delgado, Alberto Roselló-Díez, Giovanna Giovinazzo, Vanessa Cadenas, Laura Fernández-de-Manuel, Fátima Sánchez-Cabo, Matthew J. Anderson, Mark Lewandoski i Miguel Torres. "Proximo-distal positional information encoded by an Fgf-regulated gradient of homeodomain transcription factors in the vertebrate limb". Science Advances 6, nr 23 (czerwiec 2020): eaaz0742. http://dx.doi.org/10.1126/sciadv.aaz0742.
Pełny tekst źródłaSchevzov, Galina, Anthony J. Kee, Bin Wang, Vanessa B. Sequeira, Jeff Hook, Jason D. Coombes, Christine A. Lucas i in. "Regulation of cell proliferation by ERK and signal-dependent nuclear translocation of ERK is dependent on Tm5NM1-containing actin filaments". Molecular Biology of the Cell 26, nr 13 (lipiec 2015): 2475–90. http://dx.doi.org/10.1091/mbc.e14-10-1453.
Pełny tekst źródłaIhlefeld, Katja, Ralf Frederik Claas, Alexander Koch, Josef M. Pfeilschifter i Dagmar Meyer zu Heringdorf. "Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts". Biochemical Journal 447, nr 3 (5.10.2012): 457–64. http://dx.doi.org/10.1042/bj20120811.
Pełny tekst źródłaHamaguchi, Yukiyoshi, Steven K. Juhn i Yasuo Sakakura. "Protease Inhibitors in Middle Ear Effusions from Experimental Otitis Media with Effusion: Kinetics of α1-Antitrypsin and α2-Macroglobulin Levels". Annals of Otology, Rhinology & Laryngology 98, nr 4 (kwiecień 1989): 287–92. http://dx.doi.org/10.1177/000348948909800410.
Pełny tekst źródłaKundu, Mondira, Chia-Ying Yang, Kelly McCastlain, Junmin Wu, Ji Zhang, Tullia Lindsten, Paul Ney i Craig B. Thompson. "Hsp90 regulates Ulk1-mediated autophagic clearance of mitochondria". Blood 112, nr 11 (16.11.2008): 3458. http://dx.doi.org/10.1182/blood.v112.11.3458.3458.
Pełny tekst źródłaWeddle, Carly, i Paul Burridge. "Abstract A070: Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer". Cancer Research 84, nr 3_Supplement_1 (1.02.2024): A070. http://dx.doi.org/10.1158/1538-7445.advbc23-a070.
Pełny tekst źródłaYu, Lanlan, Baohui Wang, Xurui Sun i Jian Song. "Synthesis and properties of a MEAS quadripolymer scale inhibitor". Desalination and Water Treatment 52, nr 10-12 (16.05.2013): 1865–71. http://dx.doi.org/10.1080/19443994.2013.792014.
Pełny tekst źródłaRenaldo, Kyle, Shelby Sloan, JiHyun Chung, Lindsay Courtney, Konstantin Shilo, William Kisseberth i Robert A. Baiocchi. "Exploring PRMT5 As a Potential Therapeutic Target in Canine Lymphomas". Blood 132, Supplement 1 (29.11.2018): 4182. http://dx.doi.org/10.1182/blood-2018-99-119115.
Pełny tekst źródłaAlexander, D. L., L. G. Ganem, P. Fernandez-Salguero, F. Gonzalez i C. R. Jefcoate. "Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis". Journal of Cell Science 111, nr 22 (15.11.1998): 3311–22. http://dx.doi.org/10.1242/jcs.111.22.3311.
Pełny tekst źródłaLambert, Michele P., Yuhuan Wang, M. Anna Kowalska i Mortimer Poncz. "Negative Paracrine Effect of Platelet Factor 4 on Megakaryopoiesis Occurs through Lipoprotein Related Protein Receptor-1 on Megakaryocytes." Blood 110, nr 11 (16.11.2007): 97. http://dx.doi.org/10.1182/blood.v110.11.97.97.
Pełny tekst źródłaKhan, Husain Yar, Sahar Bannoura, Hirva Mamdani, Amro Aboukameel, Yousef Mzannar, Yiwei Li, Mohammad Najeeb Al-Hallak i in. "Abstract 5315: Anti-tumor activity of KRASG12C inhibitors is enhanced when combined with Cdc42 effector p21-activated kinase 4 targeting agents". Cancer Research 82, nr 12_Supplement (15.06.2022): 5315. http://dx.doi.org/10.1158/1538-7445.am2022-5315.
Pełny tekst źródłaNigam, Aradhya, Walid K. Chatila, Gnana P. Krishnamoorthy, Alan L. Ho, James A. Fagin, Nikolaus D. Schultz i Brian R. Untch. "Abstract 1181: PTEN loss-of-function mutations prevalent in HRAS-mutant cancers results in resistance to targeted therapy". Cancer Research 82, nr 12_Supplement (15.06.2022): 1181. http://dx.doi.org/10.1158/1538-7445.am2022-1181.
Pełny tekst źródłaZhou, Yang, Sahar Alimohamadi, Li Wang, Ziqing Liu, Joseph B. Wall, Chaoying Yin, Jiandong Liu i Li Qian. "A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors during Early Stage of Cardiac Reprogramming". Stem Cells International 2018 (2018): 1–14. http://dx.doi.org/10.1155/2018/3814747.
Pełny tekst źródłaTanajura, Luiz, Áurea Chaves, Andrea Abizaid i José Costa Júnior. "Monotherapy with P2Y12 receptor inhibitors in patients treated by percutaneous coronary intervention". Journal of Transcatheter Interventions 29 (2.12.2021): 1–9. http://dx.doi.org/10.31160/jotci202129a202106.
Pełny tekst źródłaDinchuk, Joseph E., Carolyn Cao, Fei Huang, Karen A. Reeves, Jeanne Wang, Fanny Myers, Glenn H. Cantor i in. "Insulin Receptor (IR) Pathway Hyperactivity in IGF-IR Null Cells and Suppression of Downstream Growth Signaling Using the Dual IGF-IR/IR Inhibitor, BMS-754807". Endocrinology 151, nr 9 (7.07.2010): 4123–32. http://dx.doi.org/10.1210/en.2010-0032.
Pełny tekst źródłaHamaguchi, Yukiyoshi, Yuichi Majima, Kenji Sakakura i Yasuo Sakakura. "Lysosomal Thiol Proteases in Middle Ear Effusions". Annals of Otology, Rhinology & Laryngology 95, nr 3_suppl (maj 1986): 9–12. http://dx.doi.org/10.1177/00034894860950s303.
Pełny tekst źródłaDizaye, Kawa F., i Asmaa A. Ahmed. "Renoprotective Evaluations of Different Angiotensin Inhibitors on Diabetic Nephropathy in Rats". Middle East Journal of Internal Medicine 9, nr 3 (listopad 2016): 3–11. http://dx.doi.org/10.5742/meim.2016.92897.
Pełny tekst źródłaMack, Fiona A., Jagruti H. Patel, Mangatt P. Biju, Volker H. Haase i M. Celeste Simon. "Decreased Growth of Vhl−/− Fibrosarcomas Is Associated with Elevated Levels of Cyclin Kinase Inhibitors p21 and p27". Molecular and Cellular Biology 25, nr 11 (1.06.2005): 4565–78. http://dx.doi.org/10.1128/mcb.25.11.4565-4578.2005.
Pełny tekst źródłaShim, Sungbo, Yujin Kim, Jongdae Shin, Jieun Kim i Soochul Park. "Regulation of EphA8 Gene Expression by TALE Homeobox Transcription Factors during Development of the Mesencephalon". Molecular and Cellular Biology 27, nr 5 (18.12.2006): 1614–30. http://dx.doi.org/10.1128/mcb.01429-06.
Pełny tekst źródłaSun, Jun, Juan Kong, Yingli Duan, Frances L. Szeto, Anne Liao, James L. Madara i Yan Chun Li. "Increased NF-κB activity in fibroblasts lacking the vitamin D receptor". American Journal of Physiology-Endocrinology and Metabolism 291, nr 2 (sierpień 2006): E315—E322. http://dx.doi.org/10.1152/ajpendo.00590.2005.
Pełny tekst źródłaYerlikaya, Azmi, Scot R. Kimball i Bruce A. Stanley. "Phosphorylation of eIF2α in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase". Biochemical Journal 412, nr 3 (28.05.2008): 579–88. http://dx.doi.org/10.1042/bj20080324.
Pełny tekst źródłaSaadatzadeh, M. Reza, Khadijeh Bijangi-Vishehsaraei i Laura S. Haneline. "The Role of Stress Activated Protein Kinases in Promoting Fanconi Anemia Hematopoietic Stem and Progenitor Cell Dysfunction". Blood 112, nr 11 (16.11.2008): 1043. http://dx.doi.org/10.1182/blood.v112.11.1043.1043.
Pełny tekst źródłaIshida, Yoji, Syugo Kowata, Kazunori Murai, Tatsuo Oyake i Shigeki Ito. "TAT/HDL Induces the Phospholylation of Cofilin in the Process of Platelet Production of Megakaryocytes." Blood 104, nr 11 (16.11.2004): 2186. http://dx.doi.org/10.1182/blood.v104.11.2186.2186.
Pełny tekst źródłaSealover, Nancy, Bridget Finniff i Robert Kortum. "Abstract B033: Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers". Molecular Cancer Research 21, nr 5_Supplement (1.05.2023): B033. http://dx.doi.org/10.1158/1557-3125.ras23-b033.
Pełny tekst źródłaRubin, Elina, Agnese C. Pippione, Matthew Boyko, Giacomo Einaudi, Stefano Sainas, Massimo Collino, Carlo Cifani i in. "A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats". Brain Sciences 12, nr 1 (28.12.2021): 35. http://dx.doi.org/10.3390/brainsci12010035.
Pełny tekst źródłaGRILL, Constance, Ferdous GHEYAS, Priya DAYANANTH, Weihong JIN, Wei DING, Ping QIU, Luquan WANG, Ronald J. DOLL i Jessie M. ENGLISH. "Analysis of the ERK1,2 transcriptome in mammary epithelial cells". Biochemical Journal 381, nr 3 (27.07.2004): 635–44. http://dx.doi.org/10.1042/bj20031688.
Pełny tekst źródłaTergaonkar, Vinay, Virginie Bottero, Masahito Ikawa, Qiutang Li i Inder M. Verma. "IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy". Molecular and Cellular Biology 23, nr 22 (15.11.2003): 8070–83. http://dx.doi.org/10.1128/mcb.23.22.8070-8083.2003.
Pełny tekst źródłaTanajura, Luiz, Áurea Chaves, Rafaela Freitas, Ana Barbosa, Kelvyn Vital i José Delamain. "Aspirin versus P2Y12 inhibitors for secondary prevention after percutaneous coronary intervention". Journal of Transcatheter Interventions 31 (14.12.2023): 1–7. http://dx.doi.org/10.31160/jotci202331a202304.
Pełny tekst źródłaVanzyl, Erin J., Hadil Sayed, Alex B. Blackmore, Kayleigh R. C. Rick, Pasan Fernando i Bruce C. McKay. "The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death". PLOS ONE 15, nr 12 (28.12.2020): e0224953. http://dx.doi.org/10.1371/journal.pone.0224953.
Pełny tekst źródłaMukherjee, Kaustav, Bruce Futcher i Janet Leatherwood. "mmi1 and rep2 mRNAs are novel RNA targets of the Mei2 RNA-binding protein during early meiosis in Schizosaccharomyces pombe". Open Biology 8, nr 9 (wrzesień 2018): 180110. http://dx.doi.org/10.1098/rsob.180110.
Pełny tekst źródłaGreene, Teshell K., Li Zhai, Beatrice Razzo, Karen Vo, Denise E. Sabatino, Rodney M. Camire, Valder R. Arruda i Mortimer Poncz. "Platelet Factor VIII-Induced Megakaryocyte Apoptosis: Implications for Hemophilia A Gene Therapy". Blood 120, nr 21 (16.11.2012): 2051. http://dx.doi.org/10.1182/blood.v120.21.2051.2051.
Pełny tekst źródłaKariya, Shin, Mitsuhiro Okano, Katsuya Aoji, Michiya Kosaka, Emiko Chikumoto, Hisashi Hattori, Koji Yuen, Shinji Nishioka, Keiko Nishioka i Kazunori Nishizaki. "Role of Macrophage Migration Inhibitory Factor in Otitis Media with Effusion in Adults". Clinical Diagnostic Laboratory Immunology 10, nr 3 (maj 2003): 417–22. http://dx.doi.org/10.1128/cdli.10.3.417-422.2003.
Pełny tekst źródłaÇAKMAK, Reşit, Ercan ÇINAR, Eyüp BAŞARAN i Mehmet BOĞA. "SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF ESTER DERIVATIVES OF 4-(DIETHYLAMINO)SALICYLALDEHYDE AS CHOLINESTERASE, AND TYROSINASE INHIBITORS". Middle East Journal of Science 7, nr 2 (30.12.2021): 137–44. http://dx.doi.org/10.51477/mejs.947973.
Pełny tekst źródłaLuciana, Luciana, Firdha Senja Maelaningsih i Diah Permata Sari. "PENGGUNAAN PROTON PUMP INHIBITOR PADA PASIEN RAWAT JALAN DI RSIA DHIA CIPUTAT TANGERANG SELATAN". Edu Masda Journal 6, nr 1 (18.04.2022): 36. http://dx.doi.org/10.52118/edumasda.v6i1.151.
Pełny tekst źródłaSealover, Nancy E., i Robert L. Kortum. "Abstract 413: WT RAS signaling is an essential therapeutic target in RAS mutated cancers". Cancer Research 82, nr 12_Supplement (15.06.2022): 413. http://dx.doi.org/10.1158/1538-7445.am2022-413.
Pełny tekst źródłaMinami, Kahori, Yukihiro Tambe, Ryosuke Watanabe, Takahiro Isono, Masataka Haneda, Ken-ichi Isobe, Toshiyuki Kobayashi i in. "Suppression of Viral Replication by Stress-Inducible GADD34 Protein via the Mammalian Serine/Threonine Protein Kinase mTOR Pathway". Journal of Virology 81, nr 20 (1.08.2007): 11106–15. http://dx.doi.org/10.1128/jvi.01063-07.
Pełny tekst źródła